Rare diseases
Investigational molecules
Locations
Study on BI 706321 and Ustekinumab for Patients with Moderate to Severe Crohn's Disease
CzechiaStudy of Encorafenib, Cetuximab, and Pembrolizumab for Patients with Untreated BRAF V600E-Mutant Metastatic Colorectal Cancer
BelgiumStudy on JAB-21822 for Adults with Advanced Solid Tumors with KRAS G12C Mutation
SpainStudy on Fenebrutinib and Teriflunomide for Adults with Relapsing Multiple Sclerosis
FinlandStudy of Tucatinib and Ado-Trastuzumab Emtansine for Patients with Advanced HER2+ Breast Cancer
BelgiumStudy on the Safety and Effectiveness of TAK-755 (Apadamtase Alfa) for Patients with Severe Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
AustriaStudy on MaaT013 for Treating Acute Gastrointestinal Graft-Versus-Host Disease in Patients Not Responding to Ruxolitinib
AustriaStudy on Guselkumab for Patients with Moderate to Severe Crohn's Disease
CroatiaStudy on the Safety and Effectiveness of Ivosidenib or Enasidenib with Azacitidine for Patients with Newly Diagnosed Acute Myeloid Leukemia with IDH1 or IDH2 Mutations
FranceStudy on the Safety and Effectiveness of Motixafortide and G-CSF for Stem Cell Collection in Patients with Multiple Myeloma
GermanyStudy on the Long-Term Safety of GTX-102 for Patients with Angelman Syndrome
FranceStudy on the Effects and Safety of Prasinezumab for Patients with Early Parkinson's Disease
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.
